First Draft Of WHO’s Pandemic Treaty: IP Waivers, Tech Transfer & Price Transparency
Executive Summary
A World Health Organization negotiating body will shortly examine the “zero draft” of a proposed pandemic treaty aimed at better preparing the world for future health crises. But the international pharmaceutical industry claims the draft as currently worded could actually undermine equitable access to pandemic countermeasures.
You may also be interested in...
Countries To Discuss Pandemic Treaty Next Year Amid Industry Concern
A World Health Organization negotiating body has agreed to develop a “zero draft” of the proposed pandemic treaty for discussion at a meeting of WHO member states in February next year. But the international pharmaceutical industry has reiterated its concerns about some of the proposals being put forward.
WHO’s Draft Pandemic Treaty Calls For More Regulatory Harmonization
Regulatory convergence and the sharing of dossiers, together with the timely and equitable sharing of pathogens, could help to speed up access to diagnostics, vaccines and medications in pandemic situations, according to the first draft of the World Health Organization’s proposed pandemic treaty.
WHO’s Draft Pandemic Treaty Calls For More Regulatory Harmonization
Regulatory convergence and the sharing of dossiers, together with the timely and equitable sharing of pathogens, could help to speed up access to medicines, vaccines and diagnostics in pandemic situations, according to the first draft of the World Health Organization’s proposed pandemic treaty.